AgeX Therapeutics, Inc. (AGE)

Operating Cash Flow

-$6.68M

Quarterly · Period ending: · USD

AGE logo

AGE Operating Cash Flow

Latest reported-$6.68M
AGE Quarterly Operating Cash Flow (-$2.01M → -$6.68M)
High-resolution chart · PNG

AGE operating cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. Operating Cash Flow — Quarterly (USD)
Period endingOperating Cash Flow (USD)
-6,684,000
-4,568,000
-6,033,000
-3,850,000
-3,750,000
-4,322,000
-11,644,000
-8,919,000
0
-1,577,000
-2,052,000
-1,864,000
-2,019,000
-1,865,000
-1,321,000
-1,236,000
-1,746,000
-1,636,000
-1,647,000
-1,884,000
-1,694,000
-2,630,000
-1,620,000
-1,889,000
-2,244,000
-2,064,000
-2,411,000
-2,372,000
-2,759,000
-2,618,000
-2,046,000
-1,783,000
-2,161,000
-2,005,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.